Pelareorep
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Pelareorep, covering 2021-01-20 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer [Phase 2]